Theraclone Sciences Inc

Corporate Profile

Founded: 
2005
Registration country: 
United States
Overview 
Headquartered in Seattle, Theraclone Sciences is a discovery-stage biotech developing novel therapeutic antibodies for the treatment of infectious disease and inflammation. Our proprietary discovery platform allows us to comprehensively screen and identify the rare antibodies that select individuals produce to successfully ward off disease.

Investors

Investor Profile Amount Stage Date
ARCH Venture Partners Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup Other venture Mar 2010
ARCH Venture Partners Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup USD Series B Sep 2011
Accelerator Corp
Alexandria Real Estate Equities Inc USD Mar 2010
Alexandria Real Estate Equities Inc USD Series B Sep 2011
Amgen Inc USD Series B Sep 2011
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies USD Mar 2010
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies USD Series B Sep 2011
Healthcare Ventures LLC USD Mar 2010
Healthcare Ventures LLC USD Series B Sep 2011
MPM Asset Management LLC
MPM Capital USD Mar 2010
MPM Capital USD Series B Sep 2011
Versant Ventures USD Mar 2010

Current employees

No current employees available

add an employee

RECORD ID: 111315